Variant report
Variant | nsv527990 |
---|---|
Chromosome Location | chr5:68448694-68455166 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:11)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:11 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:68454858-68455022 | A549 | lung: | n/a | chr5:68454983-68454996 chr5:68454983-68454996 chr5:68454983-68454996 chr5:68454983-68454994 |
2 | CEBPZ | chr5:68450574-68450582 | HepG2 | liver: | n/a | n/a |
3 | CTCF | chr5:68454000-68454150 | GM06990 | blood: | n/a | n/a |
4 | CTCF | chr5:68450580-68450730 | NHLF | lung: | n/a | n/a |
5 | FOXA1 | chr5:68453944-68454279 | T-47D | breast: | n/a | n/a |
6 | FOXA1 | chr5:68453985-68454367 | T-47D | breast: | n/a | n/a |
7 | FOXA2 | chr5:68453997-68454185 | HepG2 | liver: | n/a | n/a |
8 | POLR2A | chr5:68454000-68454025 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr5:68453342-68453468 | K562 | blood: | n/a | n/a |
10 | SPI1 | chr5:68448509-68449026 | HL-60 | blood: | n/a | n/a |
11 | SPI1 | chr5:68448568-68448939 | HL-60 | blood: | n/a | n/a |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:68431059..68433417-chr5:68453828..68456749,2 | K562 | blood: | |
2 | chr5:68450558..68453533-chr5:68461225..68464745,3 | K562 | blood: | |
3 | chr5:68442716..68444754-chr5:68449777..68451574,2 | K562 | blood: | |
4 | chr5:68452099..68454629-chr5:68466441..68468788,2 | K562 | blood: | |
5 | chr5:68452033..68456569-chr5:68461553..68463610,4 | K562 | blood: | |
6 | chr5:68446696..68449610-chr5:68457555..68460307,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000220986 | TF binding region |
ENSG00000248664 | chromatin interactions |
ENSG00000134057 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4976175 | chr5:68448694-68448695 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs6868639 | chr5:68448702-68448703 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs6887755 | chr5:68448718-68448719 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs187632427 | chr5:68448726-68448727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139611286 | chr5:68448743-68448744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537079532 | chr5:68448814-68448815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565599283 | chr5:68448830-68448831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs193266792 | chr5:68448834-68448835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538977574 | chr5:68448871-68448872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551213005 | chr5:68448872-68448873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569351891 | chr5:68448877-68448878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539436517 | chr5:68448886-68448887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142806323 | chr5:68448889-68448890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146059365 | chr5:68448916-68448917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534259669 | chr5:68448962-68448963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559008928 | chr5:68448966-68448967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577128644 | chr5:68448996-68448997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79244069 | chr5:68449017-68449018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371985077 | chr5:68449026-68449027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544978841 | chr5:68449062-68449063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140000742 | chr5:68449109-68449110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575440010 | chr5:68449133-68449134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77690585 | chr5:68449178-68449179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143707316 | chr5:68449206-68449207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs60471847 | chr5:68449233-68449234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2932767 | chr5:68449239-68449240 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs567595296 | chr5:68449255-68449256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377220105 | chr5:68449263-68449264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs71622274 | chr5:68449267-68449268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369457432 | chr5:68449268-68449269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113042289 | chr5:68449271-68449272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs59378523 | chr5:68449283-68449284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113177132 | chr5:68449313-68449314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190429244 | chr5:68449328-68449329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557443513 | chr5:68449342-68449343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553138908 | chr5:68449348-68449349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112920205 | chr5:68449369-68449370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569572099 | chr5:68449410-68449411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs577886315 | chr5:68449414-68449415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4976176 | chr5:68449429-68449430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs56911258 | chr5:68449468-68449469 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs181253245 | chr5:68449486-68449487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs55696804 | chr5:68449518-68449519 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs200682791 | chr5:68449529-68449530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs60029609 | chr5:68449557-68449558 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs184305339 | chr5:68449606-68449607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377509971 | chr5:68449613-68449614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs570854111 | chr5:68449661-68449662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371002433 | chr5:68449697-68449698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs145813481 | chr5:68449793-68449794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68443600-68462000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:68445400-68452200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr5:68448400-68449200 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr5:68451400-68451800 | Enhancers | Placenta | Placenta |
5 | chr5:68451800-68452800 | Weak transcription | Placenta | Placenta |
6 | chr5:68452800-68453800 | Enhancers | Placenta | Placenta |
7 | chr5:68453800-68462000 | Weak transcription | K562 | blood |